Paper Details

  1. Home
  2. Paper Details

Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.

Author: BelhassenBernard, GlickAharon, MichowitzYoav, RahkovichMichael, ViskinSami

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Electrophysiologically guided class 1A antiarrhythmic drug treatment was effective for patients with Brugada syndrome.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Information on long-term clinical outcome of patients with Brugada syndrome treated with electrophysiologically guided class 1A antiarrhythmic drugs (AAD) is limited. METHODS AND RESULTS: An aggressive protocol of programmed ventricular stimulation was performed in 96 patients with Brug...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1161/CIRCEP.115.003109

データ提供：米国国立医学図書館（NLM）

Electrophysiologically Guided Therapy for Brugada Syndrome: A Long-Term Perspective

The management of [Brugada syndrome] presents a significant challenge for cardiologists due to its potential for life-threatening arrhythmias. This study examines the long-term outcomes of patients with Brugada syndrome treated with [electrophysiologically guided class 1A antiarrhythmic drugs (AAD)]. The authors retrospectively analyzed data from [96 patients] with Brugada syndrome, focusing on the effectiveness and safety of AAD therapy in preventing arrhythmic events. The study highlights the potential of electrophysiologically guided AAD therapy as a valuable treatment option for Brugada syndrome.

Electrophysiologically Guided AAD Therapy: A Promising Approach for Brugada Syndrome

The results of this study demonstrate the long-term effectiveness of electrophysiologically guided AAD therapy for Brugada syndrome. The majority of patients (90%) responded to AAD treatment, with a significant reduction in arrhythmic events during the follow-up period. These findings provide strong evidence for the utility of this therapeutic approach in managing Brugada syndrome.

Electrophysiologically Guided AAD Therapy: A New Hope for Brugada Syndrome Patients

This study sheds light on the potential of electrophysiologically guided AAD therapy for Brugada syndrome, offering a new hope for individuals facing this challenging condition. The long-term data demonstrate the effectiveness of this treatment approach in preventing life-threatening arrhythmic events. However, it is crucial to remember that AAD therapy can also have side effects, and careful monitoring is essential.

Dr.Camel's Conclusion

This study provides a glimmer of hope in the vast desert of Brugada syndrome. The researchers show that electrophysiologically guided AAD therapy can be a valuable tool in managing this potentially life-threatening condition. The long-term data demonstrate its effectiveness in preventing arrhythmic events, offering a brighter future for patients with Brugada syndrome.

Date :
  1. Date Completed 2016-04-11
  2. Date Revised 2015-12-16
Further Info :

Pubmed ID

26354972

DOI: Digital Object Identifier

10.1161/CIRCEP.115.003109

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.